Sodium aurothiomalate (a.k.a. gold sodium thiomalate, and sold under the brand names Myocrisin, Myochrysine, Aurolate and others) is a gold compound, first tested in 1929, that is currently used to reduce the symptoms of
It has a wide range of unpleasant side-effects, and is generally regraded as a 'last resort' medicine.
Its precise 'mechanism of action' is unknown, though it has been shown to inhibit the synthesis of prostaglandins (hormone-like lipid compounds), and several important enzymes.
Ideas for new topics, and suggested additions / corrections for old ones, are always welcome.
If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !
Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.
( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)
You are currently viewing an auto-translated version of Wikenigma
Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.
Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.